MR-Evaluation of Renal Function-After-Pancreas-transplantation (MERFAP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01537445|
Recruitment Status : Unknown
Verified February 2012 by Per Liss, Uppsala University.
Recruitment status was: Not yet recruiting
First Posted : February 23, 2012
Last Update Posted : February 23, 2012
|Condition or disease|
|Diabetes Renal Failure Pancreas Transplantation|
|Study Type :||Observational|
|Estimated Enrollment :||40 participants|
|Official Title:||MR-Evaluation of Renal Function-After-Pancreas-transplantation|
|Study Start Date :||February 2012|
|Estimated Primary Completion Date :||February 2015|
|Estimated Study Completion Date :||August 2015|
Patients with pancreastransplantation
All patients undergoing pancreas transplantation.
- Kidney function [ Time Frame: Within 3 years ]Improvements in kidney function (GFR) and proteinuria after pancreas transplantation.
- Kidney hemodynamics and oxygenation [ Time Frame: Within 3 years ]Improvements in renal blood flow and kidney tissue oxygenation after pancreas transplantation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01537445
|University Hospital||Not yet recruiting|
|Uppsala, Sweden, 75185|
|Contact: Per Liss, MD, PhD. +46186110000 email@example.com|
|Study Director:||Per Liss, MD, PhD.||Uppsala University, Uppsala, Sweden|